Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

In India, the pharmaceutical industry is an established one, whereas the biotechnology industry is in the nascent phase and has been recognised as a new driver of growth. There are more than 150 biotech companies in India and established pharmaceutical companies are also diversifying into biotechnology. The case takes a look at the pharma and biotech industries in India; how they have evolved, the relationship between the two industries, the innovations that have taken place in these industries, the emerging trends, the opportunities for the future and how the government is facilitating its growth. The case examines the competencies that India has developed in the pharma and biotech industries. It explores how these companies are endeavouring to provide better healthcare products at better prices through their expertise in pharmacology and biotechnology, and also provide high quality outsourcing services to international clients.

Teaching and learning

This item is suitable for postgraduate courses.
Location:
Industry:
Other setting(s):
1978-2004

About

Abstract

In India, the pharmaceutical industry is an established one, whereas the biotechnology industry is in the nascent phase and has been recognised as a new driver of growth. There are more than 150 biotech companies in India and established pharmaceutical companies are also diversifying into biotechnology. The case takes a look at the pharma and biotech industries in India; how they have evolved, the relationship between the two industries, the innovations that have taken place in these industries, the emerging trends, the opportunities for the future and how the government is facilitating its growth. The case examines the competencies that India has developed in the pharma and biotech industries. It explores how these companies are endeavouring to provide better healthcare products at better prices through their expertise in pharmacology and biotechnology, and also provide high quality outsourcing services to international clients.

Teaching and learning

This item is suitable for postgraduate courses.

Settings

Location:
Industry:
Other setting(s):
1978-2004

Related